Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrara

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 18, 2026
Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?Nikolaj Frost, Ludovica Mollica, Roberto Ferrara
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Shifting From a "One Size Fits All" to a Tailored Approach for Immune-Related Adverse EventsRoberto Ferrara, Corrado Campochiaro, Marina Chiara Garassino
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2022
The Anti-Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby BoomersRoberto Ferrara, Biagio Ricciuti, Chiara Ambrogio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2017
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung CancerRoberto Ferrara, Nathalie Auger, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2019
Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?Roberto Ferrara, Caroline Caramella, Benjamin Besse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2025
Response to "Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients With Resectable NSCLC: Still an Open Question" by Dafni et alDaniele Marinelli, Giuseppe Viscardi, Roberto Ferrara, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Dementia and Geriatric Cognitive Disorders|April 17, 2004
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodiesIan G McKeith, Keith A Wesnes, Elaine Perry, et al.
Cellular Immunology|February 15, 2021
Modulation of PD-1/PD-L1 axis in myeloid-derived suppressor cells by anti-cancer treatmentsElena Jachetti, Sabina Sangaletti, Claudia Chiodoni, et al.
Children (Basel, Switzerland)|December 24, 2021
A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource SettingMassimo Mapelli, Paola Zagni, Valeria Calbi, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|April 18, 2026
Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?Nikolaj Frost, Ludovica Mollica, Roberto Ferrara
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2021
Shifting From a "One Size Fits All" to a Tailored Approach for Immune-Related Adverse EventsRoberto Ferrara, Corrado Campochiaro, Marina Chiara Garassino
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2022
The Anti-Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby BoomersRoberto Ferrara, Biagio Ricciuti, Chiara Ambrogio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2017
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung CancerRoberto Ferrara, Nathalie Auger, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2019
Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?Roberto Ferrara, Caroline Caramella, Benjamin Besse, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2025
Response to "Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients With Resectable NSCLC: Still an Open Question" by Dafni et alDaniele Marinelli, Giuseppe Viscardi, Roberto Ferrara, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Dementia and Geriatric Cognitive Disorders|April 17, 2004
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodiesIan G McKeith, Keith A Wesnes, Elaine Perry, et al.
Cellular Immunology|February 15, 2021
Modulation of PD-1/PD-L1 axis in myeloid-derived suppressor cells by anti-cancer treatmentsElena Jachetti, Sabina Sangaletti, Claudia Chiodoni, et al.
Children (Basel, Switzerland)|December 24, 2021
A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource SettingMassimo Mapelli, Paola Zagni, Valeria Calbi, et al.
Pageof 15